Letter-to-the-editor: Ethical concerns over stem cell research
By Osagie Obasogie,
Los Angeles Times
| 08. 29. 2006
The recent breakthrough that may allow scientists to create human embryonic stem cells without destroying embryos may move stem cell conversations beyond the deliberative quagmire of abortion politics and embryos' moral status. But it would be misguided to think that whether or not an embryo is destroyed marks the only ethical or social concern. Stem cell research may lead to therapies for devastating diseases. But will designer medicines premised on stem cell research be affordable to anyone other than the wealthy, particularly after California's taxpayers invested nearly $6 billion in their development? How will researchers obtain the eggs necessary to pursue this research, and how will this affect women's health? How can we oversee these technologies and their applications while ensuring that a growing industry with the keys to life's building blocks acts in the public's interest?
How embryos are treated with regard to stem cell research is unquestionably important. But equally important is how we treat each other.
Related Articles
By Emily Mullin, Wired | 03.23.2026
As the Trump administration phases out the use of animal experimentation across the federal government, a biotech startup has a bold idea for an alternative to animal testing: nonsentient “organ sacks.”
Bay Area-based R3 Bio has been quietly pitching the...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...